메뉴 건너뛰기




Volumn 48, Issue 3, 2008, Pages 442-447

Botulinum toxin type A for the treatment of nummular headache: Four case studies

Author keywords

Allodynia; Botulinum toxin type A; Nummular headache

Indexed keywords

BONTA; BOTULINUM TOXIN A; GABAPENTIN; LOCAL ANESTHETIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; UNCLASSIFIED DRUG;

EID: 42049114238     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2007.00960.x     Document Type: Article
Times cited : (57)

References (20)
  • 1
    • 2942644614 scopus 로고    scopus 로고
    • Nummular headache: A prospective series of 14 new cases
    • Pareja JA, Pareja J, Barriga FJ, et al. Nummular headache: A prospective series of 14 new cases. Headache. 2004 44 : 611 614.
    • (2004) Headache. , vol.44 , pp. 611-614
    • Pareja, J.A.1    Pareja, J.2    Barriga, F.J.3
  • 3
    • 42049096800 scopus 로고    scopus 로고
    • International Headache Society. Available at:. Accessed March 2, 2007.
    • International Headache Society. Nummular headache. Available at: http://ihs-classification.org/en/02_klassifikation/05_anhang/13.07.01_anhang. html. Accessed March 2, 2007.
    • Nummular Headache
  • 4
    • 0037799862 scopus 로고    scopus 로고
    • Nummular headache: Diagnosis and treatment
    • Pareja JA, Pareja J. Nummular headache: Diagnosis and treatment. Expert Rev Neurother. 2003 3 : 289 292.
    • (2003) Expert Rev Neurother. , vol.3 , pp. 289-292
    • Pareja, J.A.1    Pareja, J.2
  • 5
    • 0042232391 scopus 로고    scopus 로고
    • Synaptic transmission: Inhibition of neurotransmitter release by botulinum toxins
    • Suppl. 1. S24.
    • Dolly O. Synaptic transmission: Inhibition of neurotransmitter release by botulinum toxins. Headache. 2003 43 (Suppl. 1 S16 S24.
    • (2003) Headache. , vol.43
    • Dolly, O.1
  • 6
    • 0842348390 scopus 로고    scopus 로고
    • Pharmacology and immunology of botulinum toxin type a
    • Aoki KR. Pharmacology and immunology of botulinum toxin type A. Clin Dermatol. 2003 21 : 476 480.
    • (2003) Clin Dermatol. , vol.21 , pp. 476-480
    • Aoki, K.R.1
  • 7
    • 0346094286 scopus 로고    scopus 로고
    • Subcutaneous administration of botulinum toxin a reduces formalin-induced pain
    • Cui M, Khanijou S, Rubino J, Aoki KR. Subcutaneous administration of botulinum toxin A reduces formalin-induced pain. Pain. 2004 107 : 125 133.
    • (2004) Pain. , vol.107 , pp. 125-133
    • Cui, M.1    Khanijou, S.2    Rubino, J.3    Aoki, K.R.4
  • 8
    • 1642568305 scopus 로고    scopus 로고
    • Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: Implications for migraine therapy
    • Durham PL, Cady R, Cady R. Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: Implications for migraine therapy. Headache. 2004 44 : 35 42.
    • (2004) Headache. , vol.44 , pp. 35-42
    • Durham, P.L.1    Cady, R.2    Cady, R.3
  • 9
    • 0033917504 scopus 로고    scopus 로고
    • Botulinum toxin type a as a migraine preventive treatment
    • for the BOTOX Migraine Clinical Research Group.
    • Silberstein S, Mathew N, Saper J, Jenkins S, for the BOTOX Migraine Clinical Research Group. Botulinum toxin type A as a migraine preventive treatment. Headache. 2000 40 : 445 450.
    • (2000) Headache. , vol.40 , pp. 445-450
    • Silberstein, S.1    Mathew, N.2    Saper, J.3    Jenkins, S.4
  • 11
    • 17244368592 scopus 로고    scopus 로고
    • ®) for the prophylactic treatment of chronic daily headache: A randomized, double-blind, placebo-controlled trial
    • for the BOTOX CDH Study Group.
    • ®) for the prophylactic treatment of chronic daily headache: A randomized, double-blind, placebo-controlled trial. Headache. 2005 45 : 293 307.
    • (2005) Headache. , vol.45 , pp. 293-307
    • Mathew, N.T.1    Frishberg, B.M.2    Gawel, M.3    Dimitrova, R.4    Gibson, J.5    Turkel, C.6
  • 12
    • 24144474227 scopus 로고    scopus 로고
    • Botulinum toxin type a for the prophylactic treatment of chronic daily headache: A randomized, double-blind, placebo-controlled trial
    • for the BoNTA-039 Study Group.
    • Silberstein SD, Stark SR, Lucas SM, Christie SN, DeGryse RE, Turkel CC, for the BoNTA-039 Study Group. Botulinum toxin type A for the prophylactic treatment of chronic daily headache: A randomized, double-blind, placebo-controlled trial. Mayo Clin Proc. 2005 80 : 1126 1137.
    • (2005) Mayo Clin Proc. , vol.80 , pp. 1126-1137
    • Silberstein, S.D.1    Stark, S.R.2    Lucas, S.M.3    Christie, S.N.4    Degryse, R.E.5    Turkel, C.C.6
  • 13
    • 34249797267 scopus 로고    scopus 로고
    • A multicentre, double-blind, randomized, placebo-controlled, parallel group study of multiple treatments of botulinum toxin type a (BoNTA) for the prophylaxis of episodic migraine headaches
    • for the European BoNTA Headache Study Group.
    • Relja M, Poole AC, Schoenen J, Pascual J, Lei X, Thompson C, for the European BoNTA Headache Study Group. A multicentre, double-blind, randomized, placebo-controlled, parallel group study of multiple treatments of botulinum toxin type A (BoNTA) for the prophylaxis of episodic migraine headaches. Cephalalgia. 2007 27 : 492 503.
    • (2007) Cephalalgia. , vol.27 , pp. 492-503
    • Relja, M.1    Poole, A.C.2    Schoenen, J.3    Pascual, J.4    Lei, X.5    Thompson, C.6
  • 14
    • 4844228651 scopus 로고    scopus 로고
    • Botulinum toxin a in the prophylactic treatment of migraine - A randomized, double-blind, placebo-controlled study
    • Evers S, Vollmer-Haase J, Schwaag S, Rahmann A, Husstedt I-W, Frese A. Botulinum toxin A in the prophylactic treatment of migraine - A randomized, double-blind, placebo-controlled study. Cephalalgia. 2004 24 : 838 843.
    • (2004) Cephalalgia. , vol.24 , pp. 838-843
    • Evers, S.1    Vollmer-Haase, J.2    Schwaag, S.3    Rahmann, A.4    Husstedt, I.-W.5    Frese, A.6
  • 15
    • 0037062612 scopus 로고    scopus 로고
    • Numular headache: A coin-shaped cephalgia
    • Pareja JA, Caminero AB, Serra J, et al. Numular headache: A coin-shaped cephalgia. Neurology. 2002 58 : 1678 1679.
    • (2002) Neurology. , vol.58 , pp. 1678-1679
    • Pareja, J.A.1    Caminero, A.B.2    Serra, J.3
  • 16
    • 33645034738 scopus 로고    scopus 로고
    • Nummular headache: First Italian case and therapeutic proposal
    • Trucco M, Mainardi F, Perego G, Zanchin G. Nummular headache: First Italian case and therapeutic proposal. Cephalalgia. 2006 26 : 354 356.
    • (2006) Cephalalgia. , vol.26 , pp. 354-356
    • Trucco, M.1    Mainardi, F.2    Perego, G.3    Zanchin, G.4
  • 18
    • 33645749131 scopus 로고    scopus 로고
    • Nummular headache: What denomination?
    • Cohen GL. Nummular headache: What denomination? Headache. 2005 45 : 1417 1418.
    • (2005) Headache. , vol.45 , pp. 1417-1418
    • Cohen, G.L.1
  • 19
  • 20
    • 0347634401 scopus 로고    scopus 로고
    • Botulinum toxin a for chronic daily headache: A randomized, placebo-controlled, parallel design study
    • Ondo WG, Vuong KD, Derman HS. Botulinum toxin A for chronic daily headache: A randomized, placebo-controlled, parallel design study. Cephalalgia. 2004 24 : 60 65.
    • (2004) Cephalalgia. , vol.24 , pp. 60-65
    • Ondo, W.G.1    Vuong, K.D.2    Derman, H.S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.